Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Campus of Savona, Savona, Italy.
, Cosenza, Italy.
Curr Pain Headache Rep. 2019 Aug 10;23(10):78. doi: 10.1007/s11916-019-0815-8.
People with headache usually experienced significantly lower health-related quality of life (HRQoL) than the healthy subjects. The goal of this systematic review was to evaluate the effectiveness of manual therapy on HRQoL in patients with tension-type headache (TTH), migraine (MH) or cervicogenic headache (CGH).
We searched randomized controlled trials (RCTs) on MEDLINE, COCHRANE and PEDro databases. Treatment was manual therapy compared to usual care or placebo. The outcome was the HRQoL that could be measured by Headache Impact Test (HIT-6), Headache Disability Inventory (HDI), Migraine Disability Assessment Questionnaire (MIDAS) and Short Form Health Survey 12/36 (SF-12/36). For the RCT internal validity, we used the Cochrane risk of bias (RoB) tool. For the level of evidence, we used the Grading of Recommendations, Assessment, Development and Evaluation approach (GRADE). We identified a total of 10 RCTs, 7 of which were included into the meta-analysis. For HIT-6 scale, meta-analysis showed statistically significant differences in favour to manual therapy both after treatment (mean difference (MD) - 3.67; 95% CI from - 5.71 to - 1.63) and at follow-up (MD - 2.47; 95% CI from - 3.27 to - 1.68). For HDI scale, meta-analysis showed statistically significant differences in favour to manual therapy both after treatment (MD - 4.01; 95% CI from - 5.82 to - 2.20) and at follow-up (MD - 5.62; 95% CI from - 10.69 to - 0.54). Other scales provided inconclusive results. Manual therapy should be considered as an effective approach in improving the quality of life in patients with TTH and MH, while in patients with CGH, the results were inconsistent. Those positive results should be considered with caution due to the very low level of evidence. Researchers should in future design primary studies using valid and reliable disease-specific outcome measures.
头痛患者的健康相关生活质量(HRQoL)通常明显低于健康受试者。本系统综述的目的是评估手法治疗对紧张型头痛(TTH)、偏头痛(MH)或颈源性头痛(CGH)患者 HRQoL 的有效性。
我们在 MEDLINE、COCHRANE 和 PEDro 数据库中搜索了随机对照试验(RCTs)。治疗组为手法治疗,对照组为常规治疗或安慰剂。结局是可以用头痛影响测试(HIT-6)、头痛残疾程度量表(HDI)、偏头痛残疾评估问卷(MIDAS)和健康调查简表 12/36(SF-12/36)测量的 HRQoL。对于 RCT 的内部有效性,我们使用 Cochrane 偏倚风险(RoB)工具。对于证据水平,我们使用推荐评估、制定与评价分级(GRADE)方法。我们共确定了 10 项 RCT,其中 7 项被纳入荟萃分析。对于 HIT-6 量表,荟萃分析显示手法治疗在治疗后(MD-3.67;95%CI 从-5.71 到-1.63)和随访时(MD-2.47;95%CI 从-3.27 到-1.68)均有统计学意义上的优势。对于 HDI 量表,荟萃分析显示手法治疗在治疗后(MD-4.01;95%CI 从-5.82 到-2.20)和随访时(MD-5.62;95%CI 从-10.69 到-0.54)均有统计学意义上的优势。其他量表的结果不一致。手法治疗应被视为改善 TTH 和 MH 患者生活质量的有效方法,而在 CGH 患者中,结果不一致。由于证据水平极低,这些阳性结果应谨慎考虑。未来的研究人员应设计使用有效和可靠的疾病特异性结局测量的初步研究。